Westlake Corporation
WLK
$0.00
-5.37%
Westlake Corporation is a vertically integrated international manufacturer and marketer of essential materials and building products, operating in the Chemicals - Specialty industry. The company's distinct identity is built on its dual-segment structure, combining a Performance and Essential Materials business that supplies olefins and vinyl chemicals with a Housing and Infrastructure Products segment, positioning it as a diversified player across the industrial and construction value chains. The current investor narrative is dominated by the company's exposure to volatile commodity cycles, with recent headlines highlighting the impact of geopolitical tensions on global chemical supply chains and margins, driving debate around its ability to navigate a challenging pricing environment and return to profitability after a period of significant earnings pressure.…
WLK
Westlake Corporation
$0.00
WLK 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Westlake Corporation's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
8 analysts
Implied Upside
—
vs. current price
Analyst Count
8
covering this stock
Price Range
$0 - $0
Analyst target range
Westlake is covered by 8 analysts, and the institutional ratings show a mix of Buy, Neutral/Equal Weight, and Outperform recommendations, indicating a consensus that leans cautiously optimistic. The average target price is not explicitly provided in the data, but the estimated EPS average for the forward period is $4.46, which, when combined with the forward PE of 27.1x, implies a potential price target in the $121 range, suggesting modest upside from the current $112.61 price if those earnings are achieved. The target range, inferred from the estimated EPS low of $3.97 and high of $4.94, indicates a relatively tight band of expectations, signaling some consensus on the earnings recovery trajectory but also reflecting the high uncertainty inherent in a cyclical turnaround. The recent pattern of institutional ratings shows several reaffirmations of Buy and Neutral stances in Q1 2026, with one notable upgrade from BMO Capital from 'Market Perform' to 'Outperform' in early March, which could be interpreted as a positive signal regarding the company's prospects or valuation following the stock's decline and subsequent partial recovery.
Bulls vs Bears: WLK Investment Factors
The investment debate for WLK is a classic battle between deep-cyclical value and deteriorating fundamentals. The bull case, currently supported by stronger technical and valuation evidence, hinges on the stock's powerful recovery from lows, its historically cheap sales multiple, and analyst projections for a significant earnings rebound in 2026. The bear case is grounded in the harsh reality of a severe and accelerating profitability crisis, with negative gross margins and massive cash burn. The single most important tension is whether WLK can execute the dramatic earnings recovery (to ~$4.46 EPS) priced in by its forward multiple of 27.1x. If it succeeds, the stock could re-rate higher; if it fails, the current valuation discount will be justified, and the price could revisit its lows.
Bullish
- Deep Valuation Discount: WLK trades at a trailing PS ratio of 0.85, a significant discount to typical specialty chemical industry averages above 1.5x. This valuation is also near the bottom of its own historical range, which has seen PS ratios above 3x, suggesting substantial upside potential if the company's fundamentals recover.
- Strong Technical Recovery Momentum: The stock has surged 49.65% over the past six months from its 52-week low of $56.33, demonstrating powerful recovery momentum. Currently trading at $112.61, it remains 9% below its 52-week high of $124.23, indicating room for further upside in a continued bull trend.
- Analyst Consensus Points to Earnings Recovery: Analysts forecast a forward EPS of $4.46, implying a significant recovery from the current deep losses. The forward PE of 27.1x, when applied to this EPS, suggests a price target around $121, offering ~7% upside from the current price and reflecting market confidence in a turnaround.
- Solid Balance Sheet & Low Beta: WLK maintains a strong current ratio of 2.24 and a manageable debt-to-equity ratio of 0.73, providing financial flexibility. With a beta of 0.748, the stock exhibits ~25% less volatility than the market, offering a relatively lower-risk profile within the cyclical materials sector.
Bearish
- Severe and Worsening Profitability Crisis: Q4 2025 reported a catastrophic net loss of $544 million and a gross margin of -17.25%, a severe deterioration from 8.32% in Q3. The multi-quarter trend shows a rapid descent from a $7 million profit in Q4 2024, indicating intense margin compression with no clear bottom in sight.
- Persistent Revenue Contraction: Q4 2025 revenue of $2.533 billion declined 11% year-over-year, continuing a trend of deceleration. This underscores the company's acute sensitivity to weak industrial demand and volatile commodity price cycles, posing a fundamental headwind to any recovery narrative.
- Deeply Negative Free Cash Flow: Trailing twelve-month free cash flow is -$530 million, and the latest quarterly operating cash flow of $225 million was insufficient to cover capital expenditures of -$241 million. This cash burn indicates the company is not generating internal cash to fund operations, increasing reliance on its balance sheet.
- High Forward PE Implies Perfect Execution: A forward PE of 27.1x is high for a cyclical materials company and is entirely predicated on achieving the analyst-estimated EPS of $4.46. This valuation leaves no margin for error; any stumble in the expected earnings recovery would lead to significant multiple compression and price downside.
WLK Technical Analysis
The prevailing price trend for WLK is a powerful recovery and sustained uptrend from its 52-week lows, evidenced by a 1-year price change of +22.60% and a more pronounced 6-month surge of +49.65%. Currently trading at $112.61, the stock sits approximately 76% of the way up from its 52-week low of $56.33 toward its high of $124.23, indicating strong momentum but leaving room for further upside before testing major resistance. Recent short-term momentum shows signs of consolidation, with a modest 1-month gain of only 0.89%, which significantly lags the S&P 500's 7.36% gain over the same period, resulting in a stark -7.35 relative strength reading. This divergence from the strong longer-term trend suggests the stock may be taking a breather or encountering selling pressure after its sharp rally, potentially signaling a temporary pullback or rotation. Key technical levels are clearly defined by the 52-week low of $56.33 as major support and the high of $124.23 as primary resistance; a decisive breakout above $124 would confirm the bull trend's resumption, while a breakdown below the recent consolidation zone could signal a deeper correction. With a beta of 0.748, the stock has exhibited approximately 25% less volatility than the broader market over the measured period, which is notable given its cyclical nature and suggests it may offer a relatively lower-risk profile within the materials sector for position sizing.
Beta
0.75
0.75x market volatility
Max Drawdown
-47.6%
Largest decline past year
52-Week Range
$56-$124
Price range past year
Annual Return
+22.6%
Cumulative gain past year
| Period | WLK Return | S&P 500 |
|---|---|---|
| 1m | +0.0% | +9.5% |
| 3m | +28.2% | +2.7% |
| 6m | +49.6% | +5.8% |
| 1y | +22.6% | +34.9% |
| ytd | +51.9% | +4.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WLK Fundamental Analysis
Westlake's revenue trajectory reflects a challenging environment, with Q4 2025 revenue of $2.533 billion representing an 11% year-over-year decline, continuing a trend of deceleration from positive growth in prior quarters. The revenue segment data shows the Performance and Essential Materials segment contributed $1.632 billion, while Housing and Infrastructure Products contributed $901 million in the latest period, indicating the former is the larger driver, though both segments are likely facing cyclical headwinds. This persistent revenue contraction underscores the company's sensitivity to industrial demand and commodity price cycles, posing a significant headwind to the investment case. The company is currently deeply unprofitable, with Q4 2025 reporting a net loss of $544 million and a gross margin of -17.25%, a severe deterioration from the 8.32% gross margin reported in Q3 2025. The multi-quarter trend shows a rapid descent into losses, from a net income of $7 million in Q4 2024 to increasingly larger losses through 2025, indicating significant margin compression and operational challenges rather than a path toward profitability. The balance sheet and cash flow position presents a mixed picture; the company maintains a strong current ratio of 2.24 and a manageable debt-to-equity ratio of 0.73, suggesting adequate liquidity and moderate leverage. However, trailing twelve-month free cash flow is deeply negative at -$530 million, and the latest quarterly operating cash flow was a modest $225 million against capital expenditures of -$241 million, indicating the company is not generating sufficient internal cash to fund its operations and investments, increasing reliance on its balance sheet or external financing.
Quarterly Revenue
$2.5B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
-0.17%
Latest Quarter
Free Cash Flow
$-530000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WLK Overvalued?
Given the company's negative net income and negative EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio, as earnings-based multiples are not meaningful. The trailing PS ratio stands at 0.85, while the forward-looking valuation is best assessed via the forward PE of 27.1x, which implies the market is pricing in a significant recovery in earnings from the current deeply negative base. The peer comparison reveals WLK trades at a substantial discount on a sales basis; its PS ratio of 0.85 is well below typical industry averages for specialty chemicals, which often trade above 1.5x sales, suggesting the market is heavily discounting the stock due to its current unprofitability and cyclical downturn. This discount may be justified in the near term given the severe margin contraction, but it also presents a potential opportunity if the company can execute a cyclical recovery. From a historical context, the current PS ratio of 0.85 is near the bottom of its own historical range observed in the provided data, which has seen PS ratios frequently above 3x and as high as 6.66x in recent years. Trading near historical valuation lows signals the market is pricing in pessimistic expectations, reflecting the current fundamental deterioration; a reversion to the mean would require a credible path to restoring sales growth and, critically, positive margins.
PE
-6.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -80x~526x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-66.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on profitability and cash generation. The company is in a deep earnings crisis, with Q4 2025 net losses of $544 million and a gross margin of -17.25%, indicating severe operational inefficiency or pricing pressure. The trailing FCF of -$530 million shows it is burning cash, increasing reliance on its balance sheet despite a solid current ratio of 2.24. Revenue concentration in cyclical commodity chemicals and building products exposes it to industrial demand swings, as evidenced by the 11% YoY revenue decline. The path to restoring positive cash flow is unclear and represents the paramount financial risk.
Market & Competitive Risks are elevated due to WLK's cyclical nature and current premium forward valuation. Trading at a forward PE of 27.1x, the stock is priced for a perfect earnings recovery. Any disappointment versus the $4.46 EPS estimate would trigger significant multiple compression. Geopolitical tensions, as highlighted in recent news regarding commodity supply shocks from the Iran conflict, directly threaten input costs and margins for its chemical operations. While its beta of 0.748 suggests lower market volatility, the stock remains highly sensitive to global industrial growth and commodity cycles, which are currently presenting headwinds.
The Worst-Case Scenario involves a failure to stem losses, leading to a breakdown of the earnings recovery thesis. This could be triggered by a deeper-than-expected industrial recession, sustained negative gross margins, and consecutive quarterly misses versus analyst estimates. In this adverse scenario, the stock could retest its 52-week low of $56.33, representing a downside of approximately -50% from the current price of $112.61. A more realistic bear-case target, aligned with a failed recovery narrative, might be in the $70-$80 range, implying a -30% to -38% drawdown. The key risk is that the current valuation, while low on a sales basis, does not provide a floor if losses persist and the balance sheet deteriorates.